|
End-of-day quote
Korea S.E.
10/11/2026
|
5-day change | 1st Jan Change | ||
| 1,900.00 KRW | +1.50% |
|
-0.26% | -79.02% |
| 10-23 | LabGenomics Co., Ltd. authorizes a Buyback Plan. | CI |
| 10-23 | LabGenomics Co., Ltd. announces an Equity Buyback for 613,496 shares. | CI |
Company Valuation: LabGenomics Co., Ltd.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 213,662 | 280,899 | 214,147 | 286,195 | 184,858 | 134,449 |
| Change | - | 31.47% | -23.76% | 33.64% | -35.41% | -27.27% |
| Enterprise Value (EV) 1 | 165,969 | 187,221 | 98,404 | 220,799 | 144,195 | 131,929 |
| Change | - | 12.81% | -47.44% | 124.38% | -34.69% | -8.51% |
| P/E | 4.85x | 3.35x | 4.41x | -61x | -7.77x | -2.09x |
| PBR | 2.62x | 1.76x | 1.02x | 1.26x | 0.85x | 0.9x |
| PEG | - | 0x | -0.1x | 1x | -0x | -0x |
| Capitalization / Revenue | 1.79x | 1.39x | 1.48x | 3.91x | 2.15x | 1.53x |
| EV / Revenue | 1.39x | 0.92x | 0.68x | 3.02x | 1.68x | 1.5x |
| EV / EBITDA | 2.85x | 1.74x | 1.4x | -246x | -16.2x | -2.96x |
| EV / EBIT | 3.02x | 1.79x | 1.49x | -32.5x | -7.8x | -2.4x |
| EV / FCF | 4.64x | 5.24x | 4.87x | 254x | -10.2x | -17.9x |
| FCF Yield | 21.5% | 19.1% | 20.5% | 0.39% | -9.78% | -5.58% |
| Dividend per Share 2 | - | 250 | - | - | - | - |
| Rate of return | - | 1.2% | - | - | - | - |
| EPS 2 | 3,247 | 6,225 | 3,572 | -316.1 | -1,603 | -4,336 |
| Distribution rate | - | 4.02% | - | - | - | - |
| Net sales 1 | 119,478 | 202,407 | 144,773 | 73,127 | 85,898 | 88,161 |
| EBITDA 1 | 58,333 | 107,858 | 70,171 | -897.7 | -8,891 | -44,607 |
| EBIT 1 | 54,906 | 104,518 | 66,206 | -6,794 | -18,491 | -54,917 |
| Net income 1 | 42,766 | 83,855 | 48,397 | -4,674 | -23,796 | -64,375 |
| Net Debt 1 | -47,694 | -93,678 | -115,743 | -65,396 | -40,662 | -2,520 |
| Reference price 2 | 15,750.00 | 20,833.33 | 15,750.00 | 19,275.00 | 12,450.00 | 9,055.00 |
| Nbr of stocks (in thousands) | 13,566 | 13,483 | 13,597 | 14,848 | 14,848 | 14,848 |
| Announcement Date | 19/03/21 | 23/03/22 | 20/03/23 | 20/03/24 | 18/03/25 | 23/03/26 |
1KRW in Million2KRW
Estimates
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | - | - | - | 20.66M | |
| 12.11x | 0.39x | 7.87x | 3.14% | 109B | |
| 16.68x | 1.97x | 9.82x | 0.62% | 105B | |
| -208.9x | 15.12x | -232.49x | -.--% | 46.46B | |
| 16.34x | 1.7x | 10.23x | 2.18% | 33.1B | |
| 27.35x | 2.38x | 13.53x | 0.78% | 30.19B | |
| 25.15x | 2.78x | 14.1x | 1.27% | 28.57B | |
| 7.95x | 1.5x | 6.6x | -.--% | 23B | |
| 29.55x | 5.28x | 21.62x | 2.36% | 19.97B | |
| 29.8x | 2.82x | 12.67x | 1.49% | 16.76B | |
| Average | -4.89x | 3.77x | -15.12x | 1.32% | 41B | |
| Weighted average by Cap. | -7.92x | 3.27x | -16.87x | 1.48% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- A084650 Stock
- Valuation LabGenomics Co., Ltd.
Select your edition
All financial news and data tailored to specific country editions
